Biomason

company

About

Biomason is a developer of a building materials technology that employs natural microorganisms to grow bio cement in ambient temperatures.

  • 51 - 100

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.92K
Industries
Biotechnology,Building Material,Industrial
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active

Biomason is a developer of a building materials technology to produce biological cement-based building materials alternatives. Its bio cement production combines natural microorganisms and chemical processes to develop masonry materials at room temperature, which helps replace traditional clay and concrete, and the high energy consumption associated with standard manufacturing them, enabling builders to acquire alternative building materials that are produced carbon-free.

Since 2012, the company has used microorganisms to grow sustainable, structural biocement® in ambient temperatures, harnessing the power of biotechnology to reinvent traditional cement and offer a planet-friendly alternative. Biocement will eliminate 25% of the concrete industry’s global carbon emissions by 2030. Biomason bio cement is in use in projects throughout the US and Europe, and bioLITH precast tile products are commercially available.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$3.05M
Biomason has raised a total of $3.05M in funding over 2 rounds. Their latest funding was raised on Dec 23, 2015 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2015 Series Unknown $1.50M 1 Detail
Aug 21, 2015 Grant $1.37M 1 National Science Foundation Detail
Dec 20, 2013 Grant $179.92K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Biomason is funded by 2 investors. National Science Foundation and Acorn Innovestments are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Acorn Innovestments Series Unknown